KMG Fiduciary Cuts Stake in JNJ Amid Strong Q2 Results

KMG Fiduciary Partners LLC has reduced its stake in Johnson & Johnson's shares by nearly 56% in the second quarter, according to a recent filing with the Securities and Exchange Commission. The institutional investor owned 5,239 shares of Johnson & Johnson stock after selling 6,761 shares during the period, valued at $1.33 million at the end of the most recent reporting period.

Other investors have also been buying into Johnson & Johnson. Greenberg Financial Group acquired a new stake in the company's shares in the fourth quarter, valued at $954,000. World Investment Advisors boosted its stake in Johnson & Johnson by 19.6% during the same period.

Johnson & Johnson has reported strong second-quarter results, with sales of $25.31 billion, up nearly 7% year over year and above expectations. The company also raised or reaffirmed its fiscal 2026 EPS outlook to $11.60-$11.75, supporting recent share-price gains.

Analysts are bullish on Johnson & Johnson, with a consensus target price of $268.22. However, the company's valuation and competition from Intuitive Surgical may pose risks for future growth.